Cargando…

Urinary Plasmin(ogen) as a Prognostic Factor for Hypertension

INTRODUCTION: Plasmin and its precursor, plasminogen, are detectable in urine from patients with glomerular disease. Urinary plasmin(ogen) levels correlate with blood pressure (BP) and may contribute to renal Na(+) retention by activating the epithelial Na(+) channel (ENaC). In a longitudinal nested...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ray, Evan C., Miller, Rachel G., Demko, John E., Costacou, Tina, Kinlough, Carol L., Demko, Casey L., Unruh, Mark L., Orchard, Trevor J., Kleyman, Thomas R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224670/ https://www.ncbi.nlm.nih.gov/pubmed/30450470 http://dx.doi.org/10.1016/j.ekir.2018.06.007

Ejemplares similares

Urinary Plasmin(ogen): New Predictor of Hypertension?
por: Kohan, Donald E.
Publicado: (2018)

Beneficial and Detrimental Effects of Plasmin(ogen) during Infection and Sepsis in Mice
por: Guo, Yongzhi, et al.
Publicado: (2011)

Trial of Amiloride in Type 2 Diabetes With Proteinuria
por: Unruh, Mark L., et al.
Publicado: (2017)

Bacillus anthracis Interacts with Plasmin(ogen) to Evade C3b-Dependent Innate Immunity
por: Chung, Myung-Chul, et al.
Publicado: (2011)

Expression and ultrastructural localization of plasmin(ogen) in the terminally differentiated layers of normal human epidermis
por: Voegeli, R., et al.
Publicado: (2019)

Differential Effect of Glycemia on the Incidence of Hypertension by Sex: The Epidemiology of Diabetes Complications study
por: Costacou, Tina, et al.
Publicado: (2013)

The Complement Binding and Inhibitory Protein CbiA of Borrelia miyamotoi Degrades Extracellular Matrix Components by Interacting with Plasmin(ogen)
por: Nguyen, Ngoc T. T., et al.
Publicado: (2018)

Cumulative Kidney Complication Risk by 50 Years of Type 1 Diabetes: The Effects of Sex, Age, and Calendar Year at Onset
por: Costacou, Tina, et al.
Publicado: (2018)

Type A Behavior and Risk of All-Cause Mortality, CAD, and CAD-Related Mortality in a Type 1 Diabetic Population: 22 Years of Follow-up in the Pittsburgh Epidemiology of Diabetes Complications Study
por: Fickley, Catherine E., et al.
Publicado: (2013)

TXNIP DNA methylation is associated with glycemic control over 28 years in type 1 diabetes: findings from the Pittsburgh Epidemiology of Diabetes Complications (EDC) study
por: Miller, Rachel G, et al.
Publicado: (2023)

Akt Links Insulin Signaling to Albumin Endocytosis in Proximal Tubule Epithelial Cells
por: Coffey, Sam, et al.
Publicado: (2015)

Oxidative Stress and Response in Relation to Coronary Artery Disease in Type 1 Diabetes
por: Costacou, Tina, et al.
Publicado: (2013)

Statin use and cognitive function in middle-aged adults with type 1 diabetes
por: Nunley, Karen A, et al.
Publicado: (2017)

DNA methylation and 28-year cardiovascular disease risk in type 1 diabetes: the Epidemiology of Diabetes Complications (EDC) cohort study
por: Miller, Rachel G., et al.
Publicado: (2023)

Integrative Cancer Genomics (IntOGen) in Biomart
por: Perez-Llamas, Christian, et al.
Publicado: (2011)

Haptoglobin Genotype and Renal Function Decline in Type 1 Diabetes
por: Costacou, Tina, et al.
Publicado: (2009)

Adiposity and Mortality in Type 1 Diabetes
por: Conway, Baqiyyah, et al.
Publicado: (2009)

Fibrin(ogen) mediates acute inflammatory responses to biomaterials
Publicado: (1993)

Fibrin(ogen) in human disease: both friend and foe
por: Vilar, Rui, et al.
Publicado: (2020)

Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges
por: Gaule, Thembaninkosi G., et al.
Publicado: (2021)

STUDIES OF THE PLASMIN SYSTEM : II. INHIBITION OF PLASMIN BY SERUM OR PLASMA
por: Norman, Philip S.
Publicado: (1958)

HDL Particle Concentration and Size Predict Incident Coronary Artery Disease Events in People with Type 1 Diabetes
por: Costacou, Tina, et al.
Publicado: (2023)

Thrombin–Fibrin(ogen) Interactions, Host Defense and Risk of Thrombosis
por: Hulshof, Anne-Marije, et al.
Publicado: (2021)

Cellular mechanisms of fibrin (ogen): insight from neurodegenerative diseases
por: Wen, Tingting, et al.
Publicado: (2023)

Plasmin, Immunity, and Surgical Site Infection
por: Hastings, Stuart, et al.
Publicado: (2021)

Plasmin and Articular Cartilage
por: Chrisman, O. Donald, et al.
Publicado: (1962)

STUDIES OF THE PLASMIN SYSTEM : III. PHYSICAL PROPERTIES OF THE TWO PLASMIN INHIBITORS IN PLASMA
por: Norman, Philip S., et al.
Publicado: (1958)

Elevation of Plasmin-α2-plasmin Inhibitor Complexes in Patients with AL Amyloidosis
por: Miyazaki, Kanji, et al.
Publicado: (2018)

Plasmin as a complement C5 convertase
por: Leung, Lawrence L., et al.
Publicado: (2016)

IntOGen-mutations identifies cancer drivers across tumor types
por: Gonzalez-Perez, Abel, et al.
Publicado: (2013)

Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study
por: Panoutsopoulou, K, et al.
Publicado: (2010)

Chaotic dynamics and fractals
por: Demko, Stephen G, et al.
Publicado: (1986)

Plasmin inhibitor interactions. The effectiveness of alpha2-plasmin inhibitor in the presence of alpha2-macroglobulin
Publicado: (1977)

Genetic Polymorphisms in the Hypothalamic Pathway in Relation to Subsequent Weight Change – The DiOGenes Study
por: Du, Huaidong, et al.
Publicado: (2011)

Spatial Distribution of Factor Xa, Thrombin, and Fibrin(ogen) on Thrombi at Venous Shear
por: Berny, Michelle A., et al.
Publicado: (2010)

The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression
por: Kołodziejczyk, Joanna, et al.
Publicado: (2013)

Serum amyloid A binds to fibrin(ogen), promoting fibrin amyloid formation
por: Page, Martin J., et al.
Publicado: (2019)

Physical Activity, Weight Loss, and Weight Maintenance in the DiOGenes Multicenter Trial
por: van Baak, Marleen A., et al.
Publicado: (2021)

Response to Comment on Nunley et al. Clinically Relevant Cognitive Impairment in Middle-Aged Adults With Childhood-Onset Type 1 Diabetes. Diabetes Care 2015;38:1768–1776
por: Nunley, Karen A., et al.
Publicado: (2016)

A Serine Protease Inhibitor, Camostat Mesilate, Suppresses Urinary Plasmin Activity and Alleviates Hypertension and Podocyte Injury in Dahl Salt-Sensitive Rats
por: Iwata, Yasunobu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_25oe396h17ir70g78rvdk0jgjs